Envoy Medical (NASDAQ:COCH – Get Free Report) and Biomerica (NASDAQ:BMRA – Get Free Report) are both small-cap healthcare companies, but which is the superior business? We will compare the two businesses based on the strength of their institutional ownership, earnings, dividends, profitability, valuation, risk and analyst recommendations.
Earnings & Valuation
This table compares Envoy Medical and Biomerica”s revenue, earnings per share (EPS) and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Envoy Medical | $240,000.00 | 191.66 | -$23.76 million | ($0.76) | -0.78 |
| Biomerica | $4.45 million | 1.17 | -$3.78 million | ($1.64) | -1.03 |
Biomerica has higher revenue and earnings than Envoy Medical. Biomerica is trading at a lower price-to-earnings ratio than Envoy Medical, indicating that it is currently the more affordable of the two stocks.
Profitability
This table compares Envoy Medical and Biomerica’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Envoy Medical | -11,304.83% | N/A | -144.13% |
| Biomerica | -115.50% | -142.81% | -77.83% |
Analyst Ratings
This is a summary of recent ratings and price targets for Envoy Medical and Biomerica, as reported by MarketBeat.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Envoy Medical | 1 | 1 | 2 | 0 | 2.25 |
| Biomerica | 1 | 0 | 0 | 0 | 1.00 |
Envoy Medical currently has a consensus target price of $2.17, indicating a potential upside of 263.60%. Biomerica has a consensus target price of $9.00, indicating a potential upside of 432.54%. Given Biomerica’s higher probable upside, analysts clearly believe Biomerica is more favorable than Envoy Medical.
Institutional and Insider Ownership
8.6% of Envoy Medical shares are held by institutional investors. Comparatively, 22.3% of Biomerica shares are held by institutional investors. 7.2% of Envoy Medical shares are held by insiders. Comparatively, 18.0% of Biomerica shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.
Volatility & Risk
Envoy Medical has a beta of 1.97, meaning that its share price is 97% more volatile than the S&P 500. Comparatively, Biomerica has a beta of 0.38, meaning that its share price is 62% less volatile than the S&P 500.
Summary
Biomerica beats Envoy Medical on 7 of the 13 factors compared between the two stocks.
About Envoy Medical
Envoy Medical, Inc., a hearing health company, provides medical technologies for the hearing loss spectrum. Its products include personal sound amplification devices; hearing aids; Esteem fully implanted active middle ear implants; auditory osseointegrated implants; and Acclaim cochlear implants. The company was formerly known as Envoy Medical Corporation and changed its name to Envoy Medical, Inc. in September 2023. Envoy Medical, Inc. was founded in 1995 and is headquartered in White Bear Lake, Minnesota.
About Biomerica
Biomerica, Inc., a biomedical technology company, develops, patents, manufactures, and markets diagnostic and therapeutic products for the detection and/or treatment of medical conditions and diseases worldwide. The company's diagnostic test kits are used to analyze blood, urine, nasal or fecal specimens from patients in the diagnosis of various diseases, food intolerances, and other medical complications; or to measure bacteria, hormones, antibodies, antigens, or other substances which may exist in the human body, stools, or blood in extremely small concentrations. It primarily sells its products for gastrointestinal diseases, food intolerances, and various esoteric tests at the physicians' offices and over-the-counter drugstores, and hospital/clinical laboratories. The company is also developing InFoods IBS, that uses a simple blood sample to identify patient-specific foods which may alleviate irritable bowel syndrome symptoms; and H. Pylori diagnostic test that indicates if a patient is infected with the H. Pylori bacteria. In addition, it develops products to indicate if a person has been infected by COVID-19. Biomerica, Inc. was incorporated in 1971 and is headquartered in Irvine, California.
Receive News & Ratings for Envoy Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Envoy Medical and related companies with MarketBeat.com's FREE daily email newsletter.
